/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

J

Jong‐Hyeon Jeong

National Cancer Institute(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

216

Papers

17.4K

Citations

46

h-index

94

i10-index

Jong‐Hyeon Jeong is an academic researcher from National Cancer Institute. The author has contributed to research in topics: Statistical Methods and Inference & Breast Cancer Treatment Studies & Statistical Methods in Clinical Trials. The author has an h-index of 46, co-authored 184 publications.

ORCID: 0000-0003-0596-2201

Research Topics

Statistical Methods and Inference Breast Cancer Treatment Studies Statistical Methods in Clinical Trials HER2/EGFR in Cancer Research Statistical Methods and Bayesian Inference

Papers by this author

works

Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer

2002 · New England Journal of Medicine · 6,131 citations

https://doi.org/10.1056/nejmoa022152

Bernard Fisher Stewart Anderson John Bryant Richard G. Margolese

Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

2014 · Journal of Clinical Oncology · 988 citations

https://doi.org/10.1200/jco.2014.55.5730

Edith A. Perez Edward H. Romond Vera J. Suman Jong‐Hyeon Jeong

Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31

2011 · Journal of Clinical Oncology · 712 citations

https://doi.org/10.1200/jco.2011.35.0868

Edith A. Perez Edward H. Romond Vera J. Suman Jong‐Hyeon Jeong

Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-Negative Breast Cancer

2009 · Journal of Clinical Oncology · 446 citations

https://doi.org/10.1200/jco.2008.19.8424

Stewart Anderson Irene Wapnir James J. Dignam Bernard Fisher

Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31

2013 · JNCI Journal of the National Cancer Institute · 113 citations

https://doi.org/10.1093/jnci/djt321

Katherine L. Pogue–Geile Chungyeul Kim Jong‐Hyeon Jeong Noriko Tanaka

Association of Polymorphisms in <i>FCGR2A</i> and <i>FCGR3A</i> With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2–Positive Breast Cancer

2016 · JAMA Oncology · 111 citations

https://doi.org/10.1001/jamaoncol.2016.4884

Patrick G. Gavin Nan Song S. Rim Kim Corey Lipchik

Research topics

topics

Statistical Methods and Inference

Breast Cancer Treatment Studies

Statistical Methods in Clinical Trials

HER2/EGFR in Cancer Research

Statistical Methods and Bayesian Inference

Chat about Author

Papers

Chat

Click to start Chat